The Food and Drug Administration will accelerate its review of the agency’s food regulatory functions in the wake of the infant formula shortage that has prompted severe criticism of FDA’s ability to react quickly to emergency situations.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.